The deubiquitinase OTUB1 inhibits gluconeogenesis by stabilizing YWHAB

Qingwen Zhao1, Qianzhuo Wang2, Bei Li1

  • 1Zhejiang Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Senile Chronic Diseases, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Zhejiang 310006, China.

Cellular Signalling
|September 13, 2024
PubMed

Insights

The deubiquitinase OTU domain-containing ubiquitin aldehyde binding protein 1 (OTUB1) inhibits hepatic gluconeogenesis. Reduced OTUB1 worsens type 2 diabetes, while its restoration improves glucose homeostasis and insulin sensitivity.

Area of Science:

  • Biochemistry
  • Metabolism
  • Endocrinology

Background:

  • Hepatic gluconeogenesis is vital for glucose homeostasis and a target for type 2 diabetes treatment.
  • The precise molecular mechanisms regulating gluconeogenesis remain incompletely understood.

Purpose of the Study:

  • To investigate the role of OTU domain-containing ubiquitin aldehyde binding protein 1 (OTUB1) in regulating hepatic gluconeogenesis.
  • To explore OTUB1's potential as a therapeutic target for type 2 diabetes.

Main Methods:

  • Examined OTUB1 expression in db/db mice and type 2 diabetes patients.
  • Assessed the impact of hepatic OTUB1 deletion and overexpression on glucose metabolism.
  • Investigated the interaction between OTUB1 and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein β (YWHAB).

Main Results:

  • Hepatic OTUB1 expression was reduced in db/db mice and type 2 diabetes patients.
  • OTUB1 deletion elevated fasting blood glucose and key gluconeogenic gene expression.
  • OTUB1 overexpression in hepatocytes improved hyperglycemia and insulin sensitivity.
  • OTUB1 directly interacts with and deubiquitinates YWHAB, a known gluconeogenesis inhibitor.

Conclusions:

  • OTUB1 plays a critical role in suppressing hepatic gluconeogenesis.
  • OTUB1 deubiquitinates YWHAB, thereby inhibiting gluconeogenesis.
  • OTUB1 represents a promising therapeutic target for managing type 2 diabetes.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
818
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.5K